Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

ClinicalTrials.gov ID: NCT04578756

Public ClinicalTrials.gov record NCT04578756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Subjects With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Study identification

NCT ID
NCT04578756
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

  • Cariprazine Flexible Dose Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2021
Primary completion
Oct 5, 2025
Completion
Oct 5, 2025
Last update posted
Oct 26, 2025

2021 – 2025

United States locations

U.S. sites
40
U.S. states
13
U.S. cities
34
Facility City State ZIP Site status
Harmonex Neuroscience Research /ID# 234938 Dothan Alabama 36303
Pillar Clinical Research /ID# 236434 Bentonville Arkansas 72712
Advanced Research Center /ID# 241903 Anaheim California 92805
Duplicate_Alliance for Research - Long Beach /ID# 236261 Long Beach California 90807
CHOC Children's Hospital /ID# 251019 Orange California 92868-4203
ATP Clinical Research- Orange /ID# 257095 Orange California 92868
Prospective Research Innovations Inc /ID# 236098 Rancho Cucamonga California 91730
University of California, San Diego Department of Psychiatry /ID# 236466 San Diego California 92103-8229
Pacific Clinical Research Management Group /ID# 234377 Upland California 91786
D&H Doral Research Center-Doral /ID# 255459 Doral Florida 33122
Sarkis Clinical Trials /ID# 236893 Gainesville Florida 32607
Galiz Research- Palmetto Medical Plaza /ID# 236277 Hialeah Florida 33016
Advanced Research Institute of Miami /ID# 242505 Homestead Florida 33030-4613
Duplicate_Sandhill Research LLC /ID# 251239 Lake Mary Florida 32746
Columbus Clinical Services, Llc /Id# 234281 Miami Florida 33125
G+C Research Group, LLC /ID# 261398 Miami Florida 33126-2018
Florida Research Center, Inc. /ID# 236515 Miami Florida 33174
Links Clinical Trials /ID# 240975 Miami Florida 33176-3227
South Florida Research Ph I-IV /ID# 237453 Miami Springs Florida 33166-7225
K2 Medical Research - Orlando - South Orlando Avenue /ID# 257528 Orlando Florida 32751
APG Research, LLC /ID# 251153 Orlando Florida 32803
D&H Tamarac Research Center /ID# 250435 Tamarac Florida 33321-2979
Atlanta Center for Medical Research /ID# 234698 Atlanta Georgia 30331
CenExcel iResearch LLC /ID# 237391 Decatur Georgia 30030
Atlanta Behavioral Research, LLC /ID# 236374 Dunwoody Georgia 30338
Ascension Illinois /ID# 235857 Hoffman Estates Illinois 60169
Med Clinical Research Partners LLC /ID# 236071 Irvington New Jersey 07111
Erie County Medical Center /ID# 237204 Buffalo New York 14215
New Dawn Psychiatric Services PLLC /ID# 236597 Kinston North Carolina 28501-1603
Quest Therapeutics of Avon Lake /ID# 235956 Avon Lake Ohio 44012
University of Cincinnati /ID# 236913 Cincinnati Ohio 45219
Cincinnati Children's Hospital /ID# 251020 Cincinnati Ohio 45229
CincyScience /ID# 236390 West Chester Ohio 45069
Cutting Edge Research Group /ID# 236664 Oklahoma City Oklahoma 73116-1423
BioBehavioral Research of Austin /ID# 236479 Austin Texas 78759
Cedar Health Research /ID# 259364 Dallas Texas 75251-2202
Red Oak Psychiatry Associates /ID# 236602 Houston Texas 77090-2641
AIM Trials /ID# 236368 Plano Texas 75093
Family Psychiatry of The Woodlands /ID# 236426 The Woodlands Texas 77381
Core Clinical Research /ID# 236409 Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04578756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04578756 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →